Story Stocks^®

UnitedHealth (UNH) is sharply higher after reporting its Q1 results this morning. The managed care and health services giant delivered a sizable EPS beat, its largest in the last five years, while revenue increased 2% yr/yr to $111.72 bln, also nicely above expectations. Additionally, the company raised its FY26 EPS guidance above expectations to greater than $18.25 from $17.75, suggesting its efforts to manage elevated medical costs through disciplined pricing, portfolio repositioning, and tighter operating execution are helping drive stronger profitability.

• Medical care ratio (MCR) of 83.9% was better than expected and down 90 bps yr/yr, reflecting pricing discipline, medical cost management, and favorable reserve development. Underlying utilization and unit cost trends remained elevated, but were broadly in line with expectations.
• UnitedHealthcare revenue increased 2% yr/yr to $86.3 bln, while earnings from operations rose nearly 10% to $5.7 bln and operating margin expanded 40 bps to 6.6%. The improvement reflects repricing across its business lines, supporting margins as it prioritizes profitability over membership growth.
• Optum was a bit softer overall, with revenue essentially flat yr/yr at $63.7 bln. Earnings from operations fell 15% to $3.3 bln, and operating margin declined 90 bps to 5.2%, reflecting continued investment and pressure in parts of the portfolio. That was a sharp sequential improvement from the 0.1% margin in Q4, with Optum Health showing better momentum from pricing and operational improvements.
• More broadly, UNH expects digital and AI investments, simpler provider workflows, and tighter operating discipline to support execution across UnitedHealthcare and Optum. Additionally, UNH noted the improved CY27 Medicare Advantage rate update should help the MA funding backdrop.

Briefing.com Analyst Insight

UNH delivered an encouraging Q1 as it made notable progress in stabilizing performance, highlighted by improvement at UnitedHealthcare and the decision to raise its FY26 EPS guidance. The better-than-expected MCR, stronger UHC margins, and improved earnings outlook suggest it is managing through elevated medical costs better than investors had feared. Optum was a bit softer, but the sequential improvement and more constructive tone around Optum Health reinforce prior commentary that UnitedHealthcare would likely show progress first. That said, there are still some important watch items. Underlying utilization trends remain elevated, and Optum still has more work to do as it looks to narrow the execution gap. Overall, the stock is rallying because the quarter marked meaningful progress, but it will be important for UNH to continue stabilizing performance and make progress against still-elevated medical cost and utilization trends.